trial
as of 2026-07-01Berberine Treat Metabolic Syndrome in Schizophrenia
NCTId NCT03251716
at a glance
— · Completed
Enrollment 36 (actual)
Sponsored by Tianjin Anding Hospital
Primary completion 2017-10-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
36 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2015-01-01
Primary completion
2017-10-30
Eligibility
FEMALE · 18 Years · 60 Years
Interventions & indications
Sponsors
Tianjin Anding HospitalLead Sponsor
Sites
1 total
Tianjin, China
Facts & assertions
4 sourced
Enrollment
36
Phase
NA
Primary Completion Date
2017-10-30
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
company
indication